Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 21, 2020; 26(11): 1172-1184
Published online Mar 21, 2020. doi: 10.3748/wjg.v26.i11.1172
Published online Mar 21, 2020. doi: 10.3748/wjg.v26.i11.1172
Factors | Univariate analysis, OR (95%CI) | P value | Multivariate analysis, OR (95%CI) | P value |
Non-robotic minimally invasive surgery | 2.333 (1.084–5.024) | 0.038 | 2.463 (1.070–5.682) | 0.034 |
Age ≥ 70 yr | 1.141 (0.546–2.388) | 0.849 | ||
Male | 4.852 (1.487–15.834) | 0.003 | 3.937 (1.157–13.333) | 0.028 |
Body mass index ≥ 23 kg/m2 | 1.064 (0.511–2.214) | > 0.999 | ||
ASA score 2 or higher | 1.135 (0.538–2.393) | 0.851 | ||
cStage II1 or more | 1.394 (0.651–2.982) | 0.416 | ||
Proximal or total gastrectomy | 2.513 (1.205–5.240) | 0.014 | 1.694 (0.722–3.974) | 0.226 |
D2 dissection | 1.023 (0.508–2.061) | > 0.999 | ||
Splenectomy | 1.579 (0.467–5.339) | 0.668 | ||
Operative time ≥ 360 min | 4.863 (1.963–12.048) | < 0.001 | 2.779 (1.003–7.701) | 0.049 |
Estimated blood loss ≥ 50 mL | 3.596 (1.682–7.687) | 0.001 | 2.204 (0.967–5.023) | 0.060 |
Tumor size ≥ 30 mm | 1.057 (0.508–2.201) | > 0.999 | ||
pStage II1 or more | 1.120 (0.531–2.363) | 0.848 | ||
Use of neoadjuvant chemotherapy | 1.599 (0.224–11.419) | 0.729 | ||
Non-qualified surgeons | 2.047 (1.018–4.118) | 0.045 | 1.852 (0.810–4.237) | 0.145 |
- Citation: Shibasaki S, Suda K, Nakauchi M, Nakamura K, Kikuchi K, Inaba K, Uyama I. Non-robotic minimally invasive gastrectomy as an independent risk factor for postoperative intra-abdominal infectious complications: A single-center, retrospective and propensity score-matched analysis. World J Gastroenterol 2020; 26(11): 1172-1184
- URL: https://www.wjgnet.com/1007-9327/full/v26/i11/1172.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i11.1172